Multiple Sclerosis and Related Disorders

To study self-reported pain early in the disease course of juvenile idiopathic arthritis (JIA) as predictor of long-term disease outcomes.. Consecutive cases of JIA with disease

Conclusion: Our study provides evidence for proteomic differences in T cells from relapsing–remitting MS patients compared to healthy controls and also identifies dysregulation

Serum levels of 25-hydroxyvi- tamin D are a biomarker of future disease activity in patients with early relapsing–remitting multiple sclerosis (RRMS), and vitamin D supplementation

whether individuals that later develop MS have shared the same environment at the same age indicating common exposure to disease factor(s), and if so at what age has this

Case presentation: We describe a LHON-MS patient with 27 years disease duration who developed severe disease activity peaking 14 months after discontinuation of natalizumab,

A) IGHV amino acid sequences (mean 1079 [SD=1213] per patient) from nine MS patients were run through predictive models to identify likely antigenic idiotopes based on HLA class

A recent study on 45 MS patients followed for 12 months reported that higher serum leptin levels at baseline was associated with greater risk of clinical relapses and MRI-activity

Nota- bly, we show that the MCL/MINCLE pathway is affected in MS, with high expression of the receptors on immune cells associat- ing with both increased MS disease activity